Literature DB >> 26867546

Atypical presentations of thrombotic thrombocytopenic purpura: a diagnostic role for ADAMTS13.

Yosef Kalish1, Amihai Rottenstreich2, Deborah Rund2, Sarit Hochberg-Klein2.   

Abstract

Thrombotic thrombocytopenic purpura (TTP) is an acute, life threatening disease. Only a minority of patients expresses the complete clinical presentation and unusual manifestations can occur. Demonstration of low activity levels of ADAMTS13 (<5 %) is highly specific for the diagnosis of TTP. This study reports a series of five cases of TTP presenting with a thrombotic event and no hematological findings. Detailed chart reviews on these patients were conducted. We identified two patients whose first attack of TTP presented as a thrombotic episode without microangiopathic hemolytic anemia and thrombocytopenia, only to be diagnosed as TTP days later, after the appearance of hematological signs. We also describe three cases of classical TTP relapsing atypically as cerebrovascular accidents without hematological signs. Low levels of ADAMTS13 activity were detected and facilitated the diagnosis. The neurological manifestations disappeared concurrent with normalization of ADAMTS13 activity level after plasma exchange. This study underscores the importance of having a high clinical suspicion of TTP in cases of thrombosis even without hematological abnormalities in patients with previous attacks of TTP. In this clinical scenario, measurement of ADAMTS13 activity is important for diagnosis and early administration of treatment.

Entities:  

Keywords:  ADAMTS13; Cerebrovascular accident; Plasma exchange; Thrombosis; Thrombotic thrombocytopenic purpura

Mesh:

Substances:

Year:  2016        PMID: 26867546     DOI: 10.1007/s11239-016-1342-7

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  20 in total

Review 1.  ADAMTS-13 assays in thrombotic thrombocytopenic purpura.

Authors:  F Peyvandi; R Palla; L A Lotta; I Mackie; M A Scully; S J Machin
Journal:  J Thromb Haemost       Date:  2010-01-21       Impact factor: 5.824

Review 2.  Life after acquired thrombotic thrombocytopenic purpura: morbidity, mortality, and risks during pregnancy.

Authors:  S K Vesely
Journal:  J Thromb Haemost       Date:  2015-06       Impact factor: 5.824

Review 3.  Methodologies and clinical utility of ADAMTS-13 activity testing.

Authors:  Sarah Just
Journal:  Semin Thromb Hemost       Date:  2010-04-13       Impact factor: 4.180

4.  Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group.

Authors:  G A Rock; K H Shumak; N A Buskard; V S Blanchette; J G Kelton; R C Nair; R A Spasoff
Journal:  N Engl J Med       Date:  1991-08-08       Impact factor: 91.245

5.  Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura.

Authors:  Cassandra C Deford; Jessica A Reese; Lauren H Schwartz; Jedidiah J Perdue; Johanna A Kremer Hovinga; Bernhard Lämmle; Deirdra R Terrell; Sara K Vesely; James N George
Journal:  Blood       Date:  2013-07-09       Impact factor: 22.113

6.  Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.

Authors:  H M Tsai; E C Lian
Journal:  N Engl J Med       Date:  1998-11-26       Impact factor: 91.245

7.  Relapsed thrombotic thrombocytopenic purpura presenting as an acute cerebrovascular accident.

Authors:  Katharine A Downes; Roslyn Yomtovian; H M Tsai; Bernard Silver; Cynthia Rutherford; Ravindra Sarode
Journal:  J Clin Apher       Date:  2004       Impact factor: 2.821

8.  Atypical presentations of thrombotic thrombocytopenic purpura.

Authors:  Timothy E O'Brien; Edward D Crum
Journal:  Int J Hematol       Date:  2002-12       Impact factor: 2.490

9.  Ten patient stories illustrating the extraordinarily diverse clinical features of patients with thrombotic thrombocytopenic purpura and severe ADAMTS13 deficiency.

Authors:  James N George; Qiaofang Chen; Cassie C Deford; Zayd Al-Nouri
Journal:  J Clin Apher       Date:  2012-08-28       Impact factor: 2.821

10.  Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies.

Authors:  Marie Scully; Beverley J Hunt; Sylvia Benjamin; Ri Liesner; Peter Rose; Flora Peyvandi; Betty Cheung; Samuel J Machin
Journal:  Br J Haematol       Date:  2012-05-25       Impact factor: 6.998

View more
  4 in total

1.  A Case of Thrombotic Thrombocytopenic Purpura without Pathognomonic Schistocytes.

Authors:  Kevin Yu; Min Yan
Journal:  Clin Pract       Date:  2021-04-13

2.  An improbable and unusual case of thrombotic thrombocytopenia purpura.

Authors:  Jaymon Patel; Preeti Patel; Zohair Ahmed
Journal:  J Community Hosp Intern Med Perspect       Date:  2016-09-07

3.  Thrombotic Thrombocytopenic Purpura Triggered by Acute Myeloid Leukemia: A Case Report.

Authors:  Ijele Adimora; Cristhiam M Rojas Hernandez
Journal:  Am J Case Rep       Date:  2022-08-30

4.  [Progress of acquired thrombotic thrombocytopenic purpura].

Authors:  H Y Bao; Y S Qiao; D P Wu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-05-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.